Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Alzheimer's Disease

  Free Subscription


Articles published in Curr Alzheimer Res

Retrieve available abstracts of 203 articles:
HTML format
Text format



Single Articles


    June 2017
  1. KOLOSOVA NG, Tyumentsev MA, Muraleva NA, Kiseleva E, et al
    Antioxidant SkQ1 Alleviates Signs of Alzheimer's Disease-like Pathology in Old OXYS Rats by Reversing Mitochondrial Deterioration.
    Curr Alzheimer Res. 2017 Jun 21. doi: 10.2174/1567205014666170621111033.
    PubMed     Text format     Abstract available


  2. PARRA MA, Mikulan E, Trujillo N, Sala SD, et al
    Brain information sharing during visual short-term memory binding yields a memory biomarker for familial Alzheimer's disease.
    Curr Alzheimer Res. 2017 Jun 14. doi: 10.2174/1567205014666170614163316.
    PubMed     Text format     Abstract available


    May 2017
  3. SILVA AR, Pinho MS, Macedo L, Moulin CJA, et al
    The cognitive effects of wearable cameras in Mild Alzheimer disease - An experimental study.
    Curr Alzheimer Res. 2017 May 30. doi: 10.2174/1567205014666170531083015.
    PubMed     Text format     Abstract available


  4. WAMS EJ, Wilcock GK, Foster RG, Wulff K, et al
    Sleep-wake patterns and cognition of older adults with amnestic mild cognitive impairment (aMCI): A comparison with cognitively healthy adults and moderate Alzheimer's disease patients.
    Curr Alzheimer Res. 2017 May 22. doi: 10.2174/1567205014666170523095634.
    PubMed     Text format     Abstract available


  5. AHMAD J, Akhter S, Rizwanullah M, Khan MA, et al
    Nanotechnology based theranostic approaches in Alzheimer's disease management: Current status and future perspective.
    Curr Alzheimer Res. 2017 May 8. doi: 10.2174/1567205014666170508121031.
    PubMed     Text format     Abstract available


  6. D ORIO B, Fracassi A, Ceru MP, Moreno S, et al
    Targeting Pparalpha In Alzheimer`s Disease.
    Curr Alzheimer Res. 2017 May 4. doi: 10.2174/1567205014666170505094549.
    PubMed     Text format     Abstract available


  7. MARCELLI S, Corbo M, Iannuzzi F, Negri L, et al
    The Involvement of Post-Translational Modifications in Alzheimer's Disease.
    Curr Alzheimer Res. 2017 May 4. doi: 10.2174/1567205014666170505095109.
    PubMed     Text format     Abstract available


  8. ZARROUK A, Debbabi M, Bezine M, Karym EM, et al
    Lipid Biomarkers in Alzheimer's Disease.
    Curr Alzheimer Res. 2017 May 4. doi: 10.2174/1567205014666170505101426.
    PubMed     Text format     Abstract available


  9. ARMAND-UGON M, Ansoleaga B, Berjaoui S, Ferrer I, et al
    Reduced mitochondrial activity is early and steady in the entorhinal cortex but it is mainly unmodified in the frontal cortex in Alzheimer's disease.
    Curr Alzheimer Res. 2017 May 4. doi: 10.2174/1567205014666170505095921.
    PubMed     Text format     Abstract available


    April 2017
  10. ALAMEDA-BAILEN JR, Salguero-Alcaniz MP, Merchan-Clavellino A, Paino-Quesada S, et al
    Cognitive Mechanisms In Decision-Making In Patients With Mild Alzheimer Disease.
    Curr Alzheimer Res. 2017 Apr 17. doi: 10.2174/1567205014666170417113834.
    PubMed     Text format     Abstract available


  11. HE J, Liao T, Zhong GX, Zhang JD, et al
    Alzheimer`s disease-like early-phase brain pathogenesis: Self-curing amelioration of neurodegeneration from pro-inflammatory 'wounding' to anti-inflammatory 'healing'.
    Curr Alzheimer Res. 2017 Apr 17. doi: 10.2174/1567205014666170417111420.
    PubMed     Text format     Abstract available


  12. GAO Y, Tan L, Yu JT, Tan L, et al
    Tau in Alzheimer's disease: Mechanisms and therapeutic strategies.
    Curr Alzheimer Res. 2017 Apr 17. doi: 10.2174/1567205014666170417111859.
    PubMed     Text format     Abstract available


  13. KOJIMA G, Liljas A, Iliffe S, Walters K, et al
    Prevalence of Frailty in Mild to Moderate Alzheimer's Disease: A Systematic Review and Meta-analysis.
    Curr Alzheimer Res. 2017 Apr 17. doi: 10.2174/1567205014666170417104236.
    PubMed     Text format     Abstract available


  14. VERITE J, Janet T, Julian A, Chassaing D, et al
    Peripheral blood mononuclear cells of Alzheimer's disease patients control CCL4 and CXCL10 levels in a human blood brain barrier model.
    Curr Alzheimer Res. 2017 Apr 17. doi: 10.2174/1567205014666170417110337.
    PubMed     Text format     Abstract available


    March 2017
  15. SHARIFLOU S, Georgevsky D, Mansour H, Rezaeian M, et al
    Diagnostic and prognostic potential of retinal biomarkers in early on-set Alzheimer`s disease.
    Curr Alzheimer Res. 2017 Mar 29. doi: 10.2174/1567205014666170329114445.
    PubMed     Text format     Abstract available


  16. ECHEVERRIA V, Barreto GE, Avila-Rodriguez M, Tarasov VV, et al
    Is VEGF a key target of cotinine and other potential therapies against Alzheimer disease?
    Curr Alzheimer Res. 2017 Mar 29. doi: 10.2174/1567205014666170329113007.
    PubMed     Text format     Abstract available


  17. DOMINGUES C, da Cruz E Silva OA, Henriques AG
    Impact of Cytokines and Chemokines on Alzheimer's Disease Neuropathological Hallmarks.
    Curr Alzheimer Res. 2017 Mar 17. doi: 10.2174/1567205014666170317113606.
    PubMed     Text format     Abstract available


  18. RODRIGUEZ-CASADO A, Toledano-Diaz A, Toledano A
    Defective Insulin Signalling, Mediated by Inflammation, Connects Obesity to Alzheimer Disease; Relevant Pharmacological Therapies and Preventive Dietary Interventions.
    Curr Alzheimer Res. 2017 Mar 16. doi: 10.2174/1567205014666170316161848.
    PubMed     Text format     Abstract available


  19. POZA J, Gomez C, Garcia M, Tola-Arribas MA, et al
    Spatio-Temporal Fluctuations of Neural Dynamics in Mild Cognitive Impairment and Alzheimer's Disease.
    Curr Alzheimer Res. 2017 Mar 9. doi: 10.2174/1567205014666170309115656.
    PubMed     Text format     Abstract available


  20. GARRE-OLMO J, Faundez-Zanuy M, Lopez-de-Ipina K, Calvo-Perxas L, et al
    Kinematic and pressure features of handwriting and drawing: preliminary results between patients with mild cognitive impairment, Alzheimer disease and healthy controls.
    Curr Alzheimer Res. 2017 Mar 9. doi: 10.2174/1567205014666170309120708.
    PubMed     Text format     Abstract available


  21. GARRARD P, Nemes V, Nikolic D, Barney A, et al
    Motif discovery in speech: Application to monitoring Alzheimer's disease.
    Curr Alzheimer Res. 2017 Mar 9. doi: 10.2174/1567205014666170309121025.
    PubMed     Text format     Abstract available


    February 2017
  22. SHARMA S, Lipincott W
    Biomarkers in Alzheimer's Disease-Recent Update.
    Curr Alzheimer Res. 2017 Feb 20. doi: 10.2174/1567205014666170220141822.
    PubMed     Text format     Abstract available


  23. KIM J, Fischer CE, Schweizer TA, Munoz DG, et al
    Gender and Pathology-Specific Effect of Apolipoprotein E Genotype on Psychosis in Alzheimer's Disease.
    Curr Alzheimer Res. 2017 Feb 20. doi: 10.2174/1567205014666170220150021.
    PubMed     Text format     Abstract available


  24. NIXON DW
    The Inverse Relationship Between Cancer and Alzheimer's Disease: A Possible Mechanism.
    Curr Alzheimer Res. 2017 Feb 16. doi: 10.2174/1567205014666170216152905.
    PubMed     Text format     Abstract available


  25. DE MARCO M, Vallelunga A, Meneghello F, Varma S, et al
    ApoE epsilon4 allele relateted alterations in hippocampal connectivity in early Alzheimer's disease support memory performance.
    Curr Alzheimer Res. 2017 Feb 6. doi: 10.2174/1567205014666170206113528.
    PubMed     Text format     Abstract available


  26. WU W, Xie S, Li B, Yang K, et al
    Protective effects of Huang-Lian-Jie-Du-Tang on Abeta25-35-induced memory deficits and oxidative stress in male rats.
    Curr Alzheimer Res. 2017 Feb 6. doi: 10.2174/1567205014666170206163158.
    PubMed     Text format     Abstract available


  27. NICOLIA V, Ciraci V, Cavallaro RA, Ferrer I, et al
    GSK3beta 5'-flanking DNA methylation and expression in Alzheimer's Disease patients.
    Curr Alzheimer Res. 2017 Feb 3. doi: 10.2174/1567205014666170203153325.
    PubMed     Text format     Abstract available


  28. LESZEK J, Tse WH, Zhang J, Avila-Rodriguez MF, et al
    Nanotechnology for Alzheimer Disease.
    Curr Alzheimer Res. 2017 Feb 3. doi: 10.2174/1567205014666170203125008.
    PubMed     Text format     Abstract available


  29. MANTZAVINOSA V, Alexiou A, Greig NH, Kamal MA, et al
    Biomarkers for Alzheimer's Disease Diagnosis.
    Curr Alzheimer Res. 2017 Feb 3. doi: 10.2174/1567205014666170203125942.
    PubMed     Text format     Abstract available


  30. AHMAD K, Baig MH, Mushtaq G, Kamal MA, et al
    Commonalities in biological pathways, genetics, and cellular mechanism between Alzheimer Disease and other neurodegenerative diseases: An in silico-updated overview.
    Curr Alzheimer Res. 2017 Feb 3. doi: 10.2174/1567205014666170203141151.
    PubMed     Text format     Abstract available


  31. REGEN F, Hellmann-Regen J, Costantini E, Reale M, et al
    Neuroinflammation and Alzheimer's Disease: Implications for Microglial Activation.
    Curr Alzheimer Res. 2017 Feb 3. doi: 10.2174/1567205014666170203141717.
    PubMed     Text format     Abstract available


  32. SHACKLETON B, Crawford F, Bachmeier C
    Apolipoprotein E-mediated modulation of ADAM10 in Alzheimer's disease.
    Curr Alzheimer Res. 2017 Feb 2. doi: 10.2174/1567205014666170203093219.
    PubMed     Text format     Abstract available


  33. CHHETRI J, King AE, Gueven N
    Alzheimer's Disease and NQO1: Is there a Link?
    Curr Alzheimer Res. 2017 Feb 2. doi: 10.2174/1567205014666170203095802.
    PubMed     Text format     Abstract available


  34. COSTA IB, Labio RW, Rasmussen LT, Viani GA, et al
    Change in INSR, APBA2 and IDE Gene Expressions in Brains of Alzheimer s Disease Patients.
    Curr Alzheimer Res. 2017 Feb 2. doi: 10.2174/1567205014666170203100734.
    PubMed     Text format     Abstract available


    January 2017
  35. DECOURT B, Drumm-Gurnee D, Wilson J, Jacobson S, et al
    Poor Safety and Tolerability Hamper Reaching a Potentially Therapeutic Dose in the Use of Thalidomide for Alzheimer's disease: Results from a Double-Blind, Placebo-Controlled Trial.
    Curr Alzheimer Res. 2017.
    PubMed     Text format     Abstract available


  36. FUKAMI Y, Ariga T, Yamada M, Yuki N, et al
    Brain gangliosides in Alzheimer's disease: Increased expression of cholinergic neuron-specific gangliosides.
    Curr Alzheimer Res. 2017.
    PubMed     Text format     Abstract available


  37. HULL M, Sadowsky C, Arai H, Le Prince Leterme G, et al
    Long-Term Extensions of Randomized Vaccination Trials of ACC-001 and QS-21 in Mild to Moderate Alzheimer's Disease.
    Curr Alzheimer Res. 2017.
    PubMed     Text format     Abstract available


  38. TERZIOGLU-USAK S, Negis Y, Karabulut DS, Zaim M, et al
    Cellular model of Alzheimer's disease: Abeta1-42 peptide induces amyloid deposition and a decrease in topo isomerase IIbeta and Nurr1 expression.
    Curr Alzheimer Res. 2017.
    PubMed     Text format     Abstract available


  39. KLIMOVA B, Kuca K
    Alzheimer's Disease and Chinese Medicine as a Useful Alternative Intervention Tool: A Mini-Review Alzheimer's Disease and Chinese Medicine.
    Curr Alzheimer Res. 2017.
    PubMed     Text format     Abstract available


  40. ANNA P, Federico S, Massimo V
    Resilience to Alzheimer's disease: the role of physical activity.
    Curr Alzheimer Res. 2017.
    PubMed     Text format     Abstract available


  41. KRANTIC S
    Editorial: From Current Diagnostic Tools and Therapeutics for Alzheimer's Disease Towards Earlier Diagnostic Markers and Treatment Targets.
    Curr Alzheimer Res. 2017;14:2-5.
    PubMed     Text format    


    December 2016
  42. BRUCKMANN S, Brenn A, Grube M, Niedrig K, et al
    Lack of P-glycoprotein Results in Impairment of Removal of Beta-Amyloid and Increased Intraparenchymal Cerebral Amyloid Angiopathy after Active Immunization in a Transgenic Mouse Model of Alzheimer's Disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  43. YU E, Liao Z, Mao D, Zhang Q, et al
    Directed functional connectivity of posterior cingulate cortex and whole brain in Alzheimer's disease and mild cognitive impairment.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  44. PU YZ, Liang L, Fu AL, Liu Y, et al
    Generation of Alzheimer's Disease Transgenic Zebrafish Expressing Human APP Mutation under Control of Zebrafish appb Promotor.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


    November 2016
  45. MIRZA Z, Beg MA
    Molecular Interactions of Bexarotene - A Retinoid Drug And Alzheimer's Abeta Peptide: A Docking Study.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  46. ZHU R, Liu X, He Z
    Association of rs610932 and rs670139 Polymorphisms in the MS4A Gene Cluster with Alzheimer's Disease: An Updated Meta-analysis.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  47. ROUCH L, Cestac P, Cool C, Helmer C, et al
    Effectiveness of a standardized and specific follow-up in memory centers in patients with Alzheimer's disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  48. IVACHTCHENKO AV, Ivanenkov YA, Veselov MS
    Preclinical evaluation of AVN-322, novel and highly selective 5-HT6 receptor antagonist, for the treatment of Alzheimer's disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


    October 2016
  49. SEIDL C, de Moraes Santos CA, De Simone A, Bartolini M, et al
    Uleine disrupts key enzymatic and non-enzymatic biomarkers that leads to Alzheimer's disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  50. XU DS, Ponce F
    Deep Brain Stimulation for Alzheimer's Disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  51. ZORZETTO M, Datturi F, Divizia L, Pistono C, et al
    Complement C4A and C4B gene copy number study in Alzheimer's disease patients.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  52. ARCE-VARAS N, Abate G, Prandelli C, Martinez C, et al
    Comparison of extracellular and intracellular blood compartments highlights redox alterations in Alzheimer's and Mild Cognitive Impairment patients.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  53. BOUTAJANGOUT A, Noorwali A, Atta H, Wisniewski T, et al
    Human Umbilical Cord Stem Cell Xenografts Improve Cognitive Decline and Reduce the Amyloid Burden in a Mouse Model of Alzheimer's Disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


    September 2016
  54. DECOURT B, Lahiri DK, Sabbagh MN
    Targeting Tumor Necrosis Factor Alpha for Alzheimer's Disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  55. HSU D, Marshall GA
    Primary and Secondary Prevention Trials in Alzheimer Disease: Looking Back, Moving Forward.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  56. KAMKWALALA AR, Newhouse PA
    Beyond Acetylcholinesterase Inhibitors: Novel Cholinergic Treatments for Alzheimer's Disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  57. GONSALVEZ I, Baror R, Fried P, Santarnecchi E, et al
    Therapeutic Noninvasive Brain Stimulation in Alzheimer's Disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


    August 2016

  58. Erratum: Therapeutic Approaches to Modulating Glutathione Levels as a Pharmacological Strategy in Alzheimer's Disease.
    Curr Alzheimer Res. 2016;13:1198.
    PubMed     Text format     Abstract available


  59. BUDNI J, Garcez ML, de Medeiros J, Cassaro E, et al
    The anti-inflammatory role of minocycline in Alzheimer s Disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  60. CYNA M, Lynch M, Oore JJ, Nagy PM, et al
    The benefits of exercise and metabolic interventions for the prevention and early treatment of Alzheimer's disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  61. VILLETTE V, Dutar P
    GABAergic microcircuits in Alzheimer's disease models.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  62. MA K, McLaurin J
    alpha-Melanocyte Stimulating Hormone as a Potential Therapy for Alzheimer's Disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  63. MONDRAGON-RODRIGUEZ S, Perry G, Pena-Ortega F, Williams S, et al
    Tau, Amyloid beta and Deep brain stimulation: Aiming to restore cognitive deficit in Alzheimer's disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  64. REED BT, Behar-Cohen F, Krantic S
    Seeing early signs of Alzheimer's Disease through the lens of the eye.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  65. CHATTERJEE P, Roy D
    Insight into the epigenetics of Alzheimer's disease: A computational study from human interactome.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


    July 2016
  66. DOURADO MC, Laks J
    Psychological Interventions for Neuropsychiatric Disturbances in Mild and Moderate Alzheimer's Disease: Current Evidences and Future Directions.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  67. SERAFINI G, Calcagno P, Lester D, Girardi P, et al
    Suicide Risk in Alzheimer's Disease: A Systematic Review.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  68. LIAO Y, Qi XL, Cao Y, Yu WF, et al
    Elevations in the Levels of NF-kappaB and Inflammatory Chemotactic Factors in the Brains with Alzheimer's Disease - One Mechanism May Involve alpha3 Nicotinic Acetylcholine Receptor.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


    June 2016
  69. TAKAHASHI R, Ishii K, Yokoyama K
    Validation of a New Imaging Technique Using the Glucose Metabolism to Amyloid Deposition Ratio in the Diagnosis of Alzheimer's Disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  70. CHIARAVALLOTI A, Danieli R, Lacanfora A, Palumbo B, et al
    Usefulness of 18F Florbetaben in diagnosis of Alzheimer's disease and other types of dementia.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  71. RUB U, Stratmann K, Heinsen H, Del Turco D, et al
    The brainstem tau cytoskeletal pathology of Alzheimer`s disease: A brief historical overview and description of its anatomical distribution pattern, evolutional features, pathogenetic and clinical relevance.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  72. ALVES GS, Carvalho AF, de Amorim de Carvalho L, Sudo FK, et al
    Neuroimaging findings related to behavioral disturbances in Alzheimer's disease: a systematic review.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  73. CHAKRABARTI SS, Bir A, Poddar J, Sinha M, et al
    Ceramide and sphingosine-1-phosphate in cell death pathways: Relevance to the pathogenesis of Alzheimer`s disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  74. WENZLERA S, Knochela C, Balabana C, Krafta D, et al
    Integrated biomarkers for depression in Alzheimer`s disease: a critical review.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  75. PEREIRA PA, Alvim-Soares A, Bicalho MA, de Moraes EN, et al
    Lack of association between genetic polymorphism of circadian genes (PER2, PER3, CLOCK and OX2R) with late onset depression and Alzheimer's disease in a sample of a Brazilian population (Circadian Genes, Late-Onset Depression and Alzheimer's Disease).
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  76. FROST S, Guymer R, Aung KZ, Macaulay SL, et al
    Alzheimer`s disease and the early signs of age-related macular degeneration.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  77. KLIMOVA B, Kuca K
    Multi-Nutrient Dietary Intervention Approach to the Management of Alzheimer's Disease - A Mini-Review.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  78. TECCHIO F, Vecchio F, Ventriglia M, Porcaro C, et al
    Non-Ceruloplasmin Copper Appears a Disctinct Subtype of Alzheimer`s Disease: A Study of EEG-Derived Brain Activity.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  79. WANG J, Zhang X, Cheng X, Cheng J, et al
    LW-AFC, a herbal medicine for Alzheimer's disease, ameliorates cognitive deterioration and modulates neuroendocrine-immune system in senescence-accelerated mouse prone 8 strain.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  80. HEYMANN D, Stern Y, Cosentino S, Tatarina-Nulman O, et al
    The Association Between Alcohol Use and the Progression of Alzheimer's Disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


    May 2016
  81. LIU CS, Ruthirakuhan M, Chau SA, Herrmann N, et al
    Pharmacological management of agitation and aggression in Alzheimer's Disease: a review of current and novel treatments.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  82. MATURA S, Carvalho AF, Alves GS, Pantel J, et al
    Physical exercise for the treatment of neuropsychiatric disturbances in Alzheimer's dementia: possible mechanisms, current evidence and future directions.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  83. VAN DAM D, Vermeiren Y, Dekker AD, Naude PJ, et al
    Neuropsychiatric disturbances in Alzheimer's disease: what have we learned from neuropathological studies?
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


    April 2016
  84. MAGISTRI M, Velmeshev D, Makhmutova M, Patel P, et al
    The BET-bromodomain inhibitor JQ1 reduces inflammation and tau phosphorylation at Ser396 in the brain of the 3xTg model of Alzheimer's disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  85. SALAS-GONZALEZ D, Segovia F, Martinez-Murcia FJ, Lang EW, et al
    An Optimal Approach for Selecting Discriminant Regions for the Diagnosis of Alzheimer's Disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  86. DARVESH S
    Butyrylcholinesterase as a Diagnostic and Therapeutic Target for Alzheimer's Disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  87. CINZIA S, Carla P, Pietro C
    Substance P and Alzheimer's disease: emerging novel roles.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  88. QIN L, Chong T, Rodriguez R, Pugazhenthi S, et al
    Glucagon-like peptide-1-mediated modulation of inflammatory pathways in the diabetic brain: Relevance to Alzheimer's disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  89. DIBATTISTA AM, Heinsinger NM, William Rebeck G
    Alzheimer's Disease Genetic Risk Factor APOE-epsilon4 Also Affects Normal Brain Function.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  90. ZHENG L, Duan J, Duan X, Zhou W, et al
    Association of Apolipoprotein E (ApoE) polymorphism with Alzheimer's Disease in Chinese population.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


    March 2016
  91. FRINGS L, Spehl TS, Hull M, Meyer PT, et al
    Left Anterior Temporal Glucose Metabolism and not Amyloid-beta Load Predicts Naming Impairment in Alzheimer's Disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  92. JI L, Zhao X, Lu W, Zhang Q, et al
    Intracellular Abeta and its Pathological Role in Alzheimer's Disease: Lessons from Cellular to Animal Models.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  93. AL-BADDAI S, Neubauer A, Tome AM, Vigneron V, et al
    Functional Biomedical Images of Alzheimer's Disease a Green's Functionbased Empirical Mode Decomposition Study.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  94. FRANCOIS M, Fenech MF, Thomas P, Hor M, et al
    High content, multi-parameter analyses in buccal cells to identify Alzheimer's disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  95. VIGNERON V, Kodewitz A, Tomeb AM, Lelandais S, et al
    Alzheimer's disease brain areas: the machine learning support for blind localization.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  96. KRASHENYI I, Ramirez J, Popov A, Gorriz JM, et al
    Fuzzy Computer-Aided Alzheimer's Disease Diagnosis Based on MRI Data.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  97. MARTINEZ-MURCIAA FJ, Gorriza JM, Ramireza J, Ortizb For The Alzheimer's Disease Neuroimaging Initiative A, et al
    A Spherical Brain Mapping of MR Images for the Detection of Alzheimer's Disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  98. BALI P, Lahiri DK, Banik A, Nehru B, et al
    Potential for Stem Cells Therapy in Alzheimer's disease: Do neurotrophic factors play critical role?
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  99. REGE SD, Geetha T, Broderick TL, Babu JR, et al
    Can Diet and Physical Activity limit Alzheimer's disease Risk?
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  100. MCNAMARA J, Murray TA
    Connections between Herpes Simplex Virus Type 1 and Alzheimer's Disease Pathogenesis.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  101. DORSZEWSKA J, Prendecki M, Oczkowska A, Dezor M, et al
    Molecular basis of familial and sporadic Alzheimer's disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  102. LU W, Yang S, Zhang L, Chen L, et al
    Decreased Myelinated Fibers in the Hippocampal Dentate Gyrus of the Tg2576 Mouse Model of Alzheimer's Disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  103. FISAR Z, Hroudova J, Hansikova H, Spacilova J, et al
    Mitochondrial respiration in the platelets of patients with Alzheimer's disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  104. WEI W, Bodles-Brakhop AM, Barger SW
    A Role for P-Glycoprotein in Clearance of Alzheimer Amyloid beta-Peptide from the Brain.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


    February 2016
  105. FERNANDEZ AP, Masa JS, Guedan MA, Futch HS, et al
    Adrenomedullin Expression in Alzheimer's Brain.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  106. RODRIGUEZ JJ, Butt AM, Gardenal E, Parpura V, et al
    Complex and differential glial responses in Alzheimer s disease and ageing.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  107. DJORDJEVIC J, Sabbir MG, Albensi BC
    Traumatic brain injury as a risk factor for Alzheimer's disease: Is inflammatory signaling a key player?
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  108. GOLDECK D, Witkowski JM, Fulop T, Pawelec G, et al
    Peripheral immune signatures in Alzheimer Disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  109. MARNANE M, Hsiung GR
    Could better phenotyping small vessel disease provide new insights into Alzheimer Disease and improve clinical trial outcomes?
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  110. MORRIS G, Berk M
    The Putative Use of Lithium in Alzheimer's Disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  111. SUGIMOTO T, Ono R, Murata S, Saji N, et al
    Prevalence and associated factors of sarcopenia in elderly subjects with amnestic mild cognitive impairment or Alzheimer disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


    January 2016
  112. YANG KC, Chen HH
    Probabilistic cost-effectiveness analysis of vaccination for mild or moderate Alzheimer's disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  113. GONZALEZ-DOMINGUEZ R, Ruperez FJ, Garcia-Barrera T, Barbas C, et al
    METABOLOMIC-DRIVEN ELUCIDATION OF SERUM DISTURBANCES ASSOCIATED WITH ALZHEIMER S DISEASE AND MILD COGNITIVE IMPAIRMENT.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  114. TANG Z, Liu L, Li Y, Dong J, et al
    Urinary Metabolomics Reveals Alterations of Aromatic Amino Acid Metabolism of Alzheimer's Disease in the Transgenic CRND8 Mice.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  115. ZIYATDINOVA S, Ronnback A, Gurevicius K, Miszczuk D, et al
    Increased Epileptiform EEG Activity and Decreased Seizure Threshold in Arctic APP Transgenic Mouse Model of Alzheimer's Disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  116. COUNTS SE, He B, Prout JG, Michalski B, et al
    Cerebrospinal fluid proNGF: A putative biomarker for early Alzheimer's disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  117. DZAMBA D, Harantova L, Butenko O, Anderova M, et al
    Glial cells - the key elements of Alzheimer s disease.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  118. JI L, Zhao X, Lu W, Zhang Q, et al
    Intracellular Abeta and its pathological role in Alzheimer's disease: Lessons from cell and animal models.
    Curr Alzheimer Res. 2016.
    PubMed     Text format     Abstract available


  119. HEAD E, Lott IT, Wilcock DM, Lemere CA, et al
    Aging in Down Syndrome and the Development of Alzheimer's Disease Neuropathology.
    Curr Alzheimer Res. 2016;13:18-29.
    PubMed     Text format     Abstract available


  120. POTTER H, Granic A, Caneus J
    Role of Trisomy 21 Mosaicism in Sporadic and Familial Alzheimer's Disease.
    Curr Alzheimer Res. 2016;13:7-17.
    PubMed     Text format     Abstract available


  121. BARONE E
    Editorial: Oxidative Stress and Alzheimer Disease: Where Do We Stand?
    Curr Alzheimer Res. 2016;13:108-11.
    PubMed     Text format    


  122. CHEN Y, Yan H, Han Z, Bi Y, et al
    Functional Activity and Connectivity Differences of Five Resting-State Networks in Patients with Alzheimer's Disease or Mild Cognitive Impairment.
    Curr Alzheimer Res. 2016;13:234-42.
    PubMed     Text format     Abstract available


  123. MA J, Zhang W, Wang HF, Wang ZX, et al
    Peripheral Blood Adipokines and Insulin Levels in Patients with Alzheimer's Disease: A Replication Study and Meta-Analysis.
    Curr Alzheimer Res. 2016;13:223-33.
    PubMed     Text format     Abstract available


  124. HUANG Y, Lahiri DK
    Editorial: Translational Alzheimer's Disease Research.
    Curr Alzheimer Res. 2016;13:214.
    PubMed     Text format    


  125. WEINER MW, Gorriz JM, Ramirez J, Castiglioni I, et al
    Editorial: Statistical Signal Processing in the Analysis, Characterization and Detection of Alzheimer's Disease.
    Curr Alzheimer Res. 2016;13:466-8.
    PubMed     Text format    


  126. CHOI SS, Lee SR, Lee HJ
    Neurorestorative Role of Stem Cells in Alzheimer's Disease: Astrocyte Involvement.
    Curr Alzheimer Res. 2016;13:419-27.
    PubMed     Text format     Abstract available


  127. TOLEDANO A, Merino JJ, Rodriguez JJ
    Editorial: Neuroglia in Alzheimer's Disease: From Cohort to Contestant in the Disease Progression and its Therapy.
    Curr Alzheimer Res. 2016;13:318-20.
    PubMed     Text format    


  128. MAI S
    Editorial: Towards New Approaches in Alzheimer's Research and Alzheimer's Disease.
    Curr Alzheimer Res. 2016;13:728-9.
    PubMed     Text format    


  129. DI DOMENICO F, Pupo G, Giraldo E, Lloret A, et al
    Autoantibodies Profile in Matching CSF and Serum from AD and aMCI patients: Potential Pathogenic Role and Link to Oxidative Damage.
    Curr Alzheimer Res. 2016;13:112-22.
    PubMed     Text format     Abstract available


  130. CUI YQ, Wang Q, Zhang DM, Wang JY, et al
    Triptolide Rescues Spatial Memory Deficits and Amyloid-beta Aggregation Accompanied by Inhibition of Inflammatory Responses and MAPKs Activity in APP/PS1 Transgenic Mice.
    Curr Alzheimer Res. 2016;13:288-96.
    PubMed     Text format     Abstract available


  131. POLJAK A, Crawford JD, Smythe GA, Brodaty H, et al
    The Relationship Between Plasma Abeta Levels, Cognitive Function and Brain Volumetrics: Sydney Memory and Ageing Study.
    Curr Alzheimer Res. 2016;13:243-55.
    PubMed     Text format     Abstract available


  132. RIVERA A, Vanzuli I, Arellano JJ, Butt A, et al
    Decreased Regenerative Capacity of Oligodendrocyte Progenitor Cells (NG2-Glia) in the Ageing Brain: A Vicious Cycle of Synaptic Dysfunction, Myelin Loss and Neuronal Disruption?
    Curr Alzheimer Res. 2016;13:413-8.
    PubMed     Text format     Abstract available


  133. HOGENAUER M, Brendel M, Delker A, Darr S, et al
    Impact of MRI-based Segmentation Artifacts on Amyloid- and FDG-PET Quantitation.
    Curr Alzheimer Res. 2016;13:597-607.
    PubMed     Text format     Abstract available


  134. BRENDEL M, Reinisch V, Kalinowski E, Levin J, et al
    Hypometabolism in Brain of Cognitively Normal Patients with Depressive Symptoms is Accompanied by Atrophy-Related Partial Volume Effects.
    Curr Alzheimer Res. 2016;13:475-86.
    PubMed     Text format     Abstract available


  135. VASTA R, Augimeri A, Cerasa A, Nigro S, et al
    Hippocampal Subfield Atrophies in Converted and Not-Converted Mild Cognitive Impairments Patients by a Markov Random Fields Algorithm.
    Curr Alzheimer Res. 2016;13:566-74.
    PubMed     Text format     Abstract available


  136. WILKE C, Gillardon F, Deuschle C, Dubois E, et al
    Serum Levels of Progranulin Do Not Reflect Cerebrospinal Fluid Levels in Neurodegenerative Disease.
    Curr Alzheimer Res. 2016;13:654-62.
    PubMed     Text format     Abstract available


  137. IRWIN JA, Erisir A, Kwon I
    Oral Triphenylmethane Food Dye Analog, Brilliant Blue G, Prevents Neuronal Loss in APPSwDI/NOS2-/- Mouse Model.
    Curr Alzheimer Res. 2016;13:663-77.
    PubMed     Text format     Abstract available


  138. MA C, Zhang Y, Li X, Chen Y, et al
    The TT allele of rs405509 synergizes with APOE epsilon4 in the impairment of cognition and its underlying default mode network in non-demented elderly.
    Curr Alzheimer Res. 2016;13:708-17.
    PubMed     Text format     Abstract available


  139. SALVATORE C, Battista P, Castiglioni I
    Frontiers for the Early Diagnosis of AD by Means of MRI Brain Imaging and Support Vector Machines.
    Curr Alzheimer Res. 2016;13:509-33.
    PubMed     Text format     Abstract available


  140. GALLIVANONE F, Della Rosa PA, Castiglioni I
    Statistical Voxel-Based Methods and [18F]FDG PET Brain Imaging: Frontiers for the Diagnosis of AD.
    Curr Alzheimer Res. 2016;13:682-94.
    PubMed     Text format     Abstract available


    December 2015
  141. BECK JS, Mufson EJ, Counts SE
    Evidence for mitochondrial UPR gene activation in familial and sporadic Alzheimer's disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  142. XU J, Xia LL, Song N, Chen SD, et al
    Testosterone, Estradiol, and Sex Hormone-Binding Globulin in Alzheimer's Disease: A Meta-Analysis.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  143. VICKERS JC, Woodhouse A, Fernandez-Martos CM, Kirkcaldie MT, et al
    Defining the earliest pathological changes of Alzheimer's disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  144. BU XL, Jiao SS, Lian Y, Wang YJ, et al
    Perspectives on the tertiary prevention strategy for Alzheimer's disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


    November 2015
  145. ESTERAS N, Alquezar C, de la Encarnacion A, Martin-Requero A, et al
    Lymphocytes in Alzheimer's disease pathology: Altered signaling pathways.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  146. TEJERA D, Heneka MT
    Microglia in Alzheimer's disease: the good, the bad and the ugly.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  147. BERGERON D, Bensaidane R, Laforce R Jr
    Untangling Alzheimer's disease clinicoanatomical heterogeneity through selective network vulnerability - an effort to understand a complex disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  148. BESGA-BASTERRA A, Chyzhyk D, Gonzalez-Ortega I, Savio A, et al
    Eigenanatomy on fractional anisotropy imaging provides white matter anatomical features discriminating between Alzheimer's Disease and Late Onset Bipolar Disorder.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  149. MERINO JJ, Muneton-Gomez V, Alvarez MI, Toledano-Diaz A, et al
    Effects of CX3CR1 and fractalkine chemokines in amyloid beta clearance and p-Tau accumulation in Alzheimer,s disease (AD) rodent models: Is fractalkine a systemic biomarker for AD?
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  150. LIM D, Rodriguez-Arellano JJ, Parpura V, Zorec R, et al
    Calcium signalling toolkits in astrocytes and spatio-temporal progression of Alzheimer's disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  151. CARMONA P, Molina M, Toledano A
    Blood-based biomarkers of Alzheimer s disease: diagnostic algorithms and new technologies.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  152. TOLEDANO A, Alvarez MI, Toledano-Diaz A, Merino JJ, et al
    Brain local and regional neuroglial alterations in Alzheimer s Disease: cell types, responses and implications.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  153. SU L, Blamire AM, Watson R, He J, et al
    Cortical and subcortical changes in Alzheimer's disease: a longitudinal and quantitative MRI study.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  154. SEGOVIA F, G'orriz JM, Ram'irez J, Phillips C, et al
    Combining feature extraction methods to assist the diagnosis of Alzheimer's disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  155. MARTINEZ-MURCIA FJ, Gorriz JM, Ramirez J, Ortiz A, et al
    A Statistical Projection of MRI Brain Images for the Detection of Alzheimer's Disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  156. ZIPPO AG, Castiglioni I
    Integration of 18FDG-PET Metabolic and Functional Connectomes in the Early Diagnosis and Prognosis of the Alzheimer's Disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


    October 2015
  157. HERRAN E, Perez-Gonzalez R, Igartua M, Pedraz JL, et al
    Enhanced hippocampal neurogenesis in APP/Ps1 mouse model of Alzheimer's disease after implantation of VEGF-loaded PLGA nanospheres.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  158. KARA F, Hofling C, Rossner S, Schliebs R, et al
    In vivo longitudinal monitoring of changes in the corpus callosum integrity during disease progression in a mouse model of Alzheimer's disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  159. RASMUSSEN L, Delabio R, Viani GA, Chen E, et al
    Differential Expression of Ribosomal Genes in Brain and Blood of Alzheimer's Disease Patients.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  160. ZIVKOVIC L, Bajic V, Perry G, Spremo-Potparevica B, et al
    Alterations of the X Chromosome in Lymphocytes of Alzheimer's Disease Patients.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  161. LIN TW, Liu YF, Shih HS, Chen SJ, et al
    Neurodegeneration in amygdala precedes hippocampus in the APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  162. WIESMANN M, Capone C, Zerbi V, Mellendijk L, et al
    Hypertension impairs cerebral blood flow in a mouse model for Alzheimer's disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  163. BOIOCCHI C, Maggioli E, Monti MC, Zorzetto M, et al
    The Possible Involved of HLA Class III Haplotype (RAGE, HSP70 and TNF Genes) in Alzheimer's Disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  164. SALEHI A, Ashford JW, Mufson EJ
    Editorial: The Link between Alzheimer's Disease and Down Syndrome. A Historical Perspective.
    Curr Alzheimer Res. 2015.
    PubMed     Text format    


    September 2015
  165. HAMLETT E, Boger HA, Ledreux A, Kelley CM, et al
    Cognitive Impairment, Neuroimaging, and Alzheimer Neuropathology in Mouse Models of Down Syndrome.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  166. PHILLIPS C, Fahimi A, Das D, Mojabi FS, et al
    Noradrenergic System in Down Syndrome and Alzheimer's Disease A Target for Therapy.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  167. IULITA MF, Claudio Cuello CA
    The NGF Metabolic Pathway in the CNS and its Dysregulation in Down Syndrome and Alzheimer's disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  168. STRUPP BJ, Powers BE, Velazquez R, Ash JA, et al
    Maternal choline supplementation:A potential prenatal treatment for Down syndrome and Alzheimer's disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  169. SERINI S, Calviello G
    Reduction of oxidative/nitrosative stress in brain and its involvement in the neuroprotective effect of n-3 PUFA in Alzheimer's disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  170. LLORET A, Fuchsberger T, Giraldo E, Vina J, et al
    Reductive stress: A new concept in Alzheimer's disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  171. GIUDETTI AM, Romano A, Lavecchia AM, Gaetani S, et al
    The role of brain cholesterol and its oxidized products in Alzheimer's disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


    July 2015
  172. COUPLAND KG, Kim WS, Halliday GM, Hallupp M, et al
    Effect of PSEN1 mutations on MAPT methylation in early-onset Alzheimer's disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  173. INEKCI D, Henriksen K, Linemann T, Karsdal MA, et al
    Serum fragments of Tau for the differential diagnosis of Alzheimer's disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  174. BEAUCHET O, Cp L, Montero-Odasso M, Annweiler C, et al
    Anti-dementia drugs-related changes in gait performance while single and dual tasking in patients with Alzheimer disease: a meta-analysis.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  175. SUI X, Zhu M, Cui Y, Yu C, et al
    Functional connectivity hubs could serve as a potential biomarker in Alzheimer's disease: a reproducible study.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  176. CHENG XR, Cui XL, Zheng Y, Zhang GR, et al
    A co-module regulated by therapeutic drugs in a molecular subnetwork of Alzheimer's disease identified on the basis of traditional Chinese medicine and SAMP8 mice.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  177. EL HAJ M, Raffard S, Antoine P, Gely-Nargeot MC, et al
    Emotion and destination memory in Alzheimer's Disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  178. PLAGG B, Ehrlich D, Kniewallner KM, Marksteiner J, et al
    Increased acetylation of histone H4 at lysine 12 (H4K12) in monocytes of transgenic Alzheimer's mice and in human patients.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  179. FERRARI R, Ferrara M, Alinani A, Sutton RB, et al
    Screening of Early and Late Onset Alzheimer's Disease Genetic Risk Factors in a Cohort of Dementia Patients from Liguria, Italy.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  180. NUZZO D, Picone P, Baldassano S, Caruana L, et al
    Insulin Resistance as Common Molecular Denominator Linking Obesity to Alzheimer's Disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  181. ZHANG Y, Wang F, Luo X, Wang L, et al
    Cognitive improvement by photic stimulation in a mouse model of Alzheimer's disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  182. VOLGYI K, Juhasz G, Kovacs Z, Penke B, et al
    Dysfunction of Endoplasmic Reticulum (ER) and Mitochondria (MT) in Alzheimer's Disease: The Role of the ER-MT Cross-Talk.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  183. WALDRON A, Wyffels L, Verhaeghe J, Bottelbergs A, et al
    Quantitative muPET Imaging of Cerebral Glucose Metabolism and Amyloidosis in the TASTPM Double Transgenic Mouse Model of Alzheimer's Disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  184. YASUE M, Sugiura S, Uchida Y, Otake H, et al
    Prevalence of Sinusitis Detected by Magnetic Resonance Imaging in Subjects with Dementia or Alzheimer's Disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


    May 2015
  185. CM K, Jh W, Jm L, Jh R, et al
    Amyloid Beta-Weighted Cortical Thickness: A New Imaging Biomarker in Alzheimer's Disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  186. Q Z, Q G, X L, M C, et al
    Auditory Verbal Learning Test is Superior to Rey-Osterrieth Complex Figure Memory for Predicting Mild Cognitive Impairment to Alzheimer's disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


  187. B Z
    Prevention strategies targeting different preclinical stages of Alzheimer's disease.
    Curr Alzheimer Res. 2015.
    PubMed     Text format     Abstract available


    January 2015
  188. JEONG YJ, Kang GY, Kwon JH, Choi HD, et al
    1950 MHz Electromagnetic Fields Ameliorate Abeta Pathology in Alzheimer's Disease Mice.
    Curr Alzheimer Res. 2015;12:481-92.
    PubMed     Text format     Abstract available


  189. DEZSI L, Tuka B, Martos D, Vecsei L, et al
    Alzheimer's disease, astrocytes and kynurenines.
    Curr Alzheimer Res. 2015;12:462-80.
    PubMed     Text format     Abstract available


  190. MA DL, Leung CH
    Editorial: small molecule therapeutics for Alzheimer's disease.
    Curr Alzheimer Res. 2015;12:400-2.
    PubMed     Text format    


  191. RASKIN J, Cummings J, Hardy J, Schuh K, et al
    Neurobiology of Alzheimer's Disease: Integrated Molecular, Physiological, Anatomical, Biomarker, and Cognitive Dimensions.
    Curr Alzheimer Res. 2015;12:712-22.
    PubMed     Text format     Abstract available


  192. MARESOVA P, Mohelska H, Dolejs J, Kuca K, et al
    Socio-economic Aspects of Alzheimer's Disease.
    Curr Alzheimer Res. 2015;12:903-11.
    PubMed     Text format     Abstract available


  193. LAHIRI DK
    View of excellent ROAD from the CAR.
    Curr Alzheimer Res. 2015;12:96-9.
    PubMed     Text format    


  194. ZHANG Y, Zou J, Yang J, Yao Z, et al
    4Abeta1-15-Derived Monoclonal Antibody Reduces More Abeta Burdens and Neuroinflammation than Homologous Vaccine in APP/PS1 Mice.
    Curr Alzheimer Res. 2015;12:384-97.
    PubMed     Text format     Abstract available


  195. CHAO F, Zhang L, Luo Y, Xiao Q, et al
    Running Exercise Reduces Myelinated Fiber Loss in the Dentate Gyrus of the Hippocampus in APP/PS1 Transgenic Mice.
    Curr Alzheimer Res. 2015;12:377-83.
    PubMed     Text format     Abstract available


  196. ANTES R, Salomon-Zimri S, Beck SC, Garcia Garrido M, et al
    VEGF Mediates ApoE4-Induced Neovascularization and Synaptic Pathology in the Choroid and Retina.
    Curr Alzheimer Res. 2015;12:323-34.
    PubMed     Text format     Abstract available


  197. DEACON RM, Altimiras FJ, Bazan-Leon EA, Pyarasani RD, et al
    Natural AD-Like Neuropathology in Octodon degus: Impaired Burrowing and Neuroinflammation.
    Curr Alzheimer Res. 2015;12:314-22.
    PubMed     Text format     Abstract available


  198. WONG CY, Chung LH, Lu L, Wang M, et al
    Dual Inhibition And Monitoring Of Beta-amyloid Fibrillation By A Luminescent Iridium(III) Complex.
    Curr Alzheimer Res. 2015;12:439-44.
    PubMed     Text format     Abstract available


  199. KOCHI A, Lee HJ, Vithanarachchi SM, Padmini V, et al
    Inhibitory Activity Of Curcumin Derivatives Towards Metal-free And Metal-induced Amyloid-beta Aggregation.
    Curr Alzheimer Res. 2015;12:415-23.
    PubMed     Text format     Abstract available


    January 2014
  200. ALBERT M, Soldan A, Gottesman R, McKhann G, et al
    Cognitive changes preceding clinical symptom onset of mild cognitive impairment and relationship to ApoE genotype.
    Curr Alzheimer Res. 2014;11:773-84.
    PubMed     Text format     Abstract available


  201. WAKEFIELD SJ, McGeown WJ, Shanks MF, Venneri A, et al
    Differentiating normal from pathological brain ageing using standard neuropsychological tests.
    Curr Alzheimer Res. 2014;11:765-72.
    PubMed     Text format     Abstract available


  202. WANG J, Zhang Y, Xu H, Zhu S, et al
    Fluoxetine improves behavioral performance by suppressing the production of soluble beta-amyloid in APP/PS1 mice.
    Curr Alzheimer Res. 2014;11:672-80.
    PubMed     Text format     Abstract available


  203. IYER AM, van Scheppingen J, Milenkovic I, Anink JJ, et al
    Metabotropic glutamate receptor 5 in Down's syndrome hippocampus during development: increased expression in astrocytes.
    Curr Alzheimer Res. 2014;11:694-705.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: